Remix Therapeutics
MA - WatertownBiotechnology
Focus: Remix Therapeutics is a publicly traded biotech company focused on small molecule therapies designed to reprogram RNA processing, with a novel platform targeting gene therapy applications. Based in Watertown, MA, the company is in early clinical development stage with a newly completed reverse merger and fresh $100M funding.
Profile data last refreshed 5h ago · AI intelligence enriched 3d ago
Funding Stage
PUBLIC
Open Jobs
7-1 this month
Stable — net -1 jobs in 30d
5 added, 6 removed. Backfill posture.
Should You Work at Remix Therapeutics?
AI assessmentRemix is a speculative early-stage bet suitable only for risk-tolerant scientists/operators seeking novel mechanistic exposure and equity upside, not career stability or near-term revenue momentum.
Why Work Here
- Novel platform technology: RNA processing reprogramming is an emerging therapeutic modality with limited competitors, offering technical differentiation and publication/patent opportunity.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
REM-422
Myelodysplastic SyndromesClinical Trials (1)
NCT06297941Study of REM-422 in Patients With AML or Higher Risk MDS
Phase 1Help build intelligence for Remix Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.